tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Q32 Bio chief medical officer Jason Campagna to depart
PremiumThe FlyQ32 Bio chief medical officer Jason Campagna to depart
4M ago
Oxford Biomedica completes acquisition of remaining stake in U.S. subsidiary
Premium
The Fly
Oxford Biomedica completes acquisition of remaining stake in U.S. subsidiary
4M ago
Q32 Bio Stockholders Approve Key Proposals at Annual Meeting
Premium
Company Announcements
Q32 Bio Stockholders Approve Key Proposals at Annual Meeting
4M ago
Q32 Bio price target lowered to $15 from $16 at Wells Fargo
PremiumThe FlyQ32 Bio price target lowered to $15 from $16 at Wells Fargo
7M ago
Q32 Bio Inc’s Intellectual Property Challenges: Navigating Risks and Competitive Pressures
Premium
Company Announcements
Q32 Bio Inc’s Intellectual Property Challenges: Navigating Risks and Competitive Pressures
7M ago
Q32 Bio Reports Promising Trial Results and Financials
Premium
Company Announcements
Q32 Bio Reports Promising Trial Results and Financials
7M ago
Q32 Bio downgraded to Neutral from Overweight at Piper Sandler
PremiumThe FlyQ32 Bio downgraded to Neutral from Overweight at Piper Sandler
8M ago
Q32 Bio Restructures to Focus on Bempikibart Development
Premium
Company Announcements
Q32 Bio Restructures to Focus on Bempikibart Development
8M ago
Q32 Bio announces corporate restructuring to focus on bempikibart
Premium
The Fly
Q32 Bio announces corporate restructuring to focus on bempikibart
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100